SVRA insider transaction filings
Savara Inc — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-24. Screen SVRA transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 1 Form 4 filing. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Lutz Robert Matthew — Chief Fin. & Operating Officer | 1 | — | — | 2 |
Recent Form 4 filings — Savara Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-24 | 4 | Lutz Robert Matthew — Chief Fin. & Operating Officer | Grant/award (A): 35,000 @ $0 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Lowrance David L — Chief Financial Officer | Option exercise (M): 75,000 @ $1.59 · Tax withholding (F): 21,682 @ $5.50 · Option exercise (M): 129,350 @ $1.23 · Tax withholding (F): 28,928 @ $5.50 · Option exercise (M): 56,937 @ $1.11 · Tax withholding (F): 11,491 @ $5.50 · +13 more | EDGAR |
| 2026-03-20 | 4 | Lowrance David L — Chief Financial Officer | Option exercise (M): 80,684 @ $1.51 · Tax withholding (F): 24,174 @ $5.04 · Option exercise (M): 75,000 @ $1.59 · Tax withholding (F): 23,661 @ $5.04 · Option exercise (M): 130,650 @ $1.23 · Tax withholding (F): 31,885 @ $5.04 · +12 more | EDGAR |
| 2026-02-17 | 4 | McCracken Joseph S — Director | Option exercise (M): 1,807 @ $1.76 · Option exercise (M): 1,807 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | RAMSAY DAVID A — Director | Sale (S): 20,000 @ $6.06 | EDGAR |
| 2025-12-16 | 4 | Lowrance David L — Chief Financial Officer | Tax withholding (F): 62,960 @ $6.92 · Gift (G): 32,000 @ $0 | EDGAR |
| 2025-12-16 | 4 | Pauls Matthew — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 195,705 @ $6.92 · Gift (G): 128,995 @ $0 | EDGAR |
| 2025-12-16 | 4 | Lutz Robert Matthew — Chief Operating Officer | Tax withholding (F): 67,760 @ $6.92 | EDGAR |
| 2025-12-16 | 4 | McCabe Kathleen R. — Chief Legal Officer | Tax withholding (F): 39,350 @ $6.92 | EDGAR |
| 2025-12-16 | 4 | Erickson Anne — Chief Business Officer | Tax withholding (F): 62,960 @ $6.92 | EDGAR |
| 2025-12-11 | 4 | Hawkins Richard J — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-12-11 | 4 | van Es-Johansson An — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-12-11 | 4 | Elam Nevan C — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-12-11 | 4 | RAMSAY DAVID A — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-12-11 | 4 | McCracken Joseph S — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-12-11 | 4 | Pauls Matthew — CHIEF EXECUTIVE OFFICER, Director | Gift (G): 23,629 @ $0 | EDGAR |
| 2025-12-04 | 4 | Wasfi Yasmine — Chief Medical Officer | Tax withholding (F): 21,992 @ $6.37 | EDGAR |
| 2025-12-04 | 4 | Elam Nevan C — Director | Option exercise (M): 5,860 @ $1.46 · Tax withholding (F): 1,473 @ $5.81 · Option exercise (M): 5,860 (derivative) @ $0 | EDGAR |
| 2025-11-17 | 4 | Hawkins Richard J — Director | Option exercise (M): 5,860 @ $1.46 · Option exercise (M): 5,860 (derivative) @ $0 | EDGAR |
| 2025-10-22 | 4 | Wasfi Yasmine — Chief Medical Officer | Grant/award (A): 35,000 @ $0 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Hawkins Richard J — Director | Purchase (P): 48,225 @ $2.04 | EDGAR |
| 2025-06-02 | 4 | McCracken Joseph S — Director | Purchase (P): 10,000 @ $2.08 | EDGAR |
| 2025-04-01 | 4 | RAMSAY DAVID A — Director | Purchase (P): 150,000 @ $2.77 | EDGAR |
| 2025-02-14 | 4 | Lutz Robert Matthew — Chief Operating Officer | Tax withholding (F): 38,263 @ $2.83 | EDGAR |
| 2024-12-16 | 4 | Erickson Anne — Chief Business Officer | Grant/award (A): 100,000 @ $0 · Tax withholding (F): 18,263 @ $3.21 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Parker Braden C. — Chief Commercial Officer | Grant/award (A): 20,000 @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Lutz Robert Matthew — Chief Operating Officer | Grant/award (A): 100,000 @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Lowrance David L — Chief Financial Officer | Grant/award (A): 100,000 @ $0 · Gift (G): 12,000 @ $0 · Tax withholding (F): 24,350 @ $3.21 · Sale (S): 25,000 @ $3.33 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Pratt Raymond Dennis — Chief Medical Officer | Grant/award (A): 80,000 @ $0 · Grant/award (A): 280,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Pauls Matthew — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 400,000 @ $0 · Tax withholding (F): 92,593 @ $3.21 · Sale (S): 54,702 @ $3.31 · Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Hawkins Richard J — Director | Grant/award (A): 40,000 @ $0 · Sale (S): 8,000 @ $3.32 | EDGAR |
| 2024-12-16 | 4 | Elam Nevan C — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2024-12-16 | 4 | van Es-Johansson An — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2024-12-16 | 4 | McCracken Joseph S — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2024-12-16 | 4 | RAMSAY DAVID A — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2024-11-20 | 4 | McCracken Joseph S — Director | Purchase (P): 20,000 @ $2.95 | EDGAR |
| 2024-11-18 | 4 | RAMSAY DAVID A — Director | Purchase (P): 100,000 @ $2.88 | EDGAR |
| 2024-11-12 | 4 | Pratt Raymond Dennis — Chief Medical Officer | Tax withholding (F): 49,950 @ $3.97 | EDGAR |
| 2024-10-22 | 4 | Erickson Anne — Chief Business Officer | Tax withholding (F): 381 @ $3.57 | EDGAR |
| 2024-09-27 | 4 | Parker Braden C. — Chief Commercial Officer | Grant/award (A): 85,000 @ $0 · Grant/award (A): 170,000 (derivative) @ $0 | EDGAR |
| 2024-07-22 | 4 | Erickson Anne — Chief Business Officer | Tax withholding (F): 381 @ $4.47 | EDGAR |
| 2024-04-23 | 4 | Erickson Anne — Chief Business Officer | Tax withholding (F): 381 @ $4.81 | EDGAR |
| 2023-12-29 | 4 | Pauls Matthew — CHIEF EXECUTIVE OFFICER, Director | Sale (S): 84,000 @ $4.71 · Gift (G): 19,000 @ $0 | EDGAR |
| 2023-12-29 | 4 | Lowrance David L — CHIEF FINANCIAL OFFICER | Sale (S): 10,000 @ $4.71 | EDGAR |
| 2023-12-29 | 4 | Elam Nevan C — Director | Option exercise (M): 1,758 @ $0.82 · Option exercise (M): 12,000 @ $1.59 · Option exercise (M): 40,000 @ $1.23 · Sale (S): 93,843 @ $4.71 · Option exercise (M): 1,758 (derivative) @ $0 · Option exercise (M): 12,000 (derivative) @ $0 · +1 more | EDGAR |
| 2023-12-18 | 4 | Pratt Raymond Dennis — Chief Medical Officer | Grant/award (A): 150,000 @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | Hawkins Richard J — Director | Grant/award (A): 22,500 @ $0 | EDGAR |
| 2023-12-15 | 4 | Elam Nevan C — Director | Grant/award (A): 22,500 @ $0 | EDGAR |
| 2023-12-15 | 4 | McCracken Joseph S — Director | Grant/award (A): 22,500 @ $0 | EDGAR |
| 2023-12-15 | 4 | Sun Ricky — Director | Grant/award (A): 22,500 @ $0 | EDGAR |
Recent 8-K events — Savara Inc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-06-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | EDGAR |
| 2026-01-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-02 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-06 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-05-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-31 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SVRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →